European public assessment reports

  • Email
  • Help

This page allows you to find the European public assessment reports (EPAR) for human medicines published by the European Medicines Agency (EMA).

The EMA publishes an EPAR for every medicine granted a central marketing authorisation by the European Commission following an assessment by the EMA's Committee for Medicinal Products for Human Use (CHMP). EPARs are full scientific assessment reports of medicines authorised at a European Union level. 

Use this search to find information including a public-friendly overview in question-and-answer format and the package leaflet. You can also find information on medicines that have been refused a marketing authorisation or that have been suspended or withdrawn after being approved.

As of October 2016, EMA publishes the clinical data submitted by pharmaceutical companies to support their marketing applications for human medicines under the centralised procedure, allowing the public to better understand the Agency’s decision-making. For more information see clinical data publication.

The Agency does not evaluate all medicines currently in use in Europe. If you cannot find the medicine you need through this search, please visit the website of your national health authority.

More information is available on the Central authorisation procedure and in EPARs: background and context.

Document status


Browse by letter

Browse by letter for medicines that have a European Public Assessment Report:

Or for other types of content pick from the navigation on the left.

Search by keyword

Search for keyword:

Search by therapeutic area

Browse the database based on therapeutic area:


Browse by type

Browse by type:

Download results to spreadsheet
EPAR Search results
Name Active substance Therapeutic area Date of authorisation / refusal Additional monitoring Orphan     Has current safety alert Status
Capecitabine Accord


Stomach Neoplasms 2012-04-20           Authorised
Capecitabine Teva


Stomach Neoplasms 2012-04-20           Authorised


Stomach Neoplasms 2014-12-19           Authorised
Docetaxel Teva


Stomach Neoplasms 2010-01-26           Authorised
Docetaxel Winthrop


Stomach Neoplasms 2007-04-20           Authorised
Ecansya (previously Capecitabine Krka)


Stomach Neoplasms 2012-04-20           Authorised


Stomach Neoplasms 2000-08-28           Authorised


Stomach Neoplasms 2017-11-15           Authorised
Taxespira (previously Docetaxel Hospira UK Limited )

docetaxel trihydrate

Stomach Neoplasms 2015-08-28           Authorised


Stomach Neoplasms 1995-11-27           Authorised

tegafur / gimeracil / oteracil

Stomach Neoplasms 2011-03-14           Authorised


Stomach Neoplasms 2001-02-02           Authorised